| Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections (NCT03571100) | MidAtlantic Retina | 2018-05-07 |
| Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD) (NCT03504540) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-04-05 |
| Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment (NCT04292756) | The Filatov Institute of Eye Diseases and Tissue Therapy | 2018-03-27 |
| Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (NCT03446144) | Ionis Pharmaceuticals, Inc. | 2018-03-16 |
| A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD) (NCT03150589) | Samsung Bioepis Co., Ltd. | 2018-03-14 |
| Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease (NCT03466177) | Universitaire Ziekenhuizen KU Leuven | 2018-03-01 |
| AMD Ryan Initiative Study (ARIS) (NCT03092492) | National Eye Institute (NEI) | 2018-02-12 |
| Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD) (NCT03946085) | Guardion Health Sciences, Inc. | 2018-01-19 |
| Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA (NCT03415984) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-01-19 |
| Reading Analysis in Ophthalmologic Patients (NCT03750149) | Prim. Prof. Dr. Oliver Findl, MBA | 2018-01-01 |
| An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy (NCT03117634) | Singapore National Eye Centre | 2017-12-01 |
| Polarization Perception in Health and Disease. Testing a New Sight Test (NCT03823092) | South Warwickshire NHS Foundation Trust | 2017-11-09 |
| Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension (NCT04659512) | St. Erik Eye Hospital | 2017-10-01 |
| Visual Function Tests in Age-related Macular Degeneration (NCT03275753) | ORA, Inc. | 2017-09-21 |
| Evaluate the Quality of Life of Patients With AMD (NCT03242083) | Centre Hospitalier Universitaire Dijon | 2017-08-08 |
| Dark Adaptation in Participants With Age-Related Macular Degeneration (NCT03225131) | National Eye Institute (NEI) | 2017-06-16 |
| Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning? (NCT04276610) | Université de Montréal | 2017-05-16 |
| Carbidopa-levodopa in Neovascular AMD (NCT03022318) | Snyder, Robert W., M.D., Ph.D., P.C. | 2017-05-02 |
| Dose Ranging Study of Carbidopa-levodopa (NCT03023059) | Snyder, Robert W., M.D., Ph.D., P.C. | 2017-05-02 |
| Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD (NCT04482465) | Universitaire Ziekenhuizen KU Leuven | 2017-04-20 |
| Telescope Exchange Study (NCT03011554) | VisionCare, Inc. | 2017-03-22 |
| Patient's Feelings After Receiving a Diagnosis of Age-related Macular Degeneration (NCT03035461) | Centre Hospitalier Intercommunal Creteil | 2017-03-15 |
| Macular Thickness Measurements Using Retinal-thickness OCT (NCT03030729) | Notal Vision Ltd. | 2017-03-14 |
| Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration (NCT02941263) | National Eye Institute (NEI) | 2017-03-08 |
| Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases (NCT03128463) | Xun Xu | 2017-02-28 |
| Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept (NCT03056079) | Unity Health Toronto | 2017-02-28 |
| Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab (NCT03056092) | Unity Health Toronto | 2017-02-28 |
| Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD) (NCT03668054) | Laboratorio Elea Phoenix S.A. | 2017-02-07 |
| 30g vs 33g Needle for Intravitreal Injections (NCT03038048) | Wills Eye | 2017-01-27 |
| Retinal Imaging Using NOTAL-OCT (NCT03374020) | Notal Vision Ltd. | 2017-01-17 |
| Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration (NCT03313401) | Ulucanlar Eye Training and Research Hospital | 2017-01-01 |
| Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration (NCT02564978) | National Eye Institute (NEI) | 2016-12-14 |
| An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration (NCT02848313) | Stealth BioTherapeutics Inc. | 2016-10-28 |
| Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections (NCT02951351) | Mayo Clinic | 2016-10-12 |
| Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose (NCT02864472) | Seoul National University Hospital | 2016-09-01 |
| Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration (NCT02802657) | Xiaodong Sun | 2016-09-01 |
| Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels (NCT03079570) | ORA, Inc. | 2016-08-23 |
| Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal (NCT02748824) | Association for Innovation and Biomedical Research on Light and Image | 2016-07-01 |
| A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment Tools (NCT02871817) | Digisight Technologies, Inc. | 2016-07-01 |
| Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD (NCT02800356) | Ospedale San Raffaele | 2016-06-01 |
| A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer) (NCT02387957) | Ophthotech Corporation | 2016-04-26 |
| Cytokeratin 8 Level in Age-related Macular Degeneration (NCT02707575) | Gangnam Severance Hospital | 2016-04-26 |
| Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD (NCT02727881) | Ohr Pharmaceutical Inc. | 2016-04-12 |
| Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV) (NCT02829606) | University of Minnesota | 2016-04-01 |
| Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (NCT02725762) | LumiThera, Inc. | 2016-03-01 |
| Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD (NCT03024424) | University of Utah | 2016-03-01 |
| Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation (NCT02868424) | The First Affiliated Hospital with Nanjing Medical University | 2016-02-13 |
| Head to Head Study of Anti-VEGF Treatment. (NCT02577107) | Novartis Pharmaceuticals | 2016-01-13 |
| "Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study (NCT02960828) | Seoul National University Bundang Hospital | 2016-01-01 |
| Stem Cell Ophthalmology Treatment Study II (NCT03011541) | MD Stem Cells | 2016-01-01 |
| Aflibercept in Recurrent or Persistent CNV (NCT02669953) | Medical University of Vienna | 2015-12-01 |
| Alpha Lipoic Acid in Geographic Atrophy (NCT02613572) | University of Pennsylvania | 2015-11-01 |
| Non-invasive Optical Angiography in Age-related Macular Degeneration (NCT02521142) | Medical University of Vienna | 2015-11-01 |
| Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective (NCT02567604) | Queen's University, Belfast | 2015-10-01 |
| Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté (NCT02626377) | Centre Hospitalier Universitaire de Besancon | 2015-10-01 |
| A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration (NCT02555306) | Santen Inc. | 2015-09-16 |
| Visual Activity Evoked by Infrared in Humans After Dark Adaptation (NCT02909985) | University of New Mexico | 2015-09-01 |
| Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (NCT02563782) | Astellas Institute for Regenerative Medicine | 2015-08-24 |
| Resveratrol for Exudative Age-Related Macular Degeneration (NCT02625376) | Poitiers University Hospital | 2015-08-06 |
| Stem Cell Therapy for Outer Retinal Degenerations (NCT02903576) | Federal University of São Paulo | 2015-08-01 |
| Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors (NCT01918553) | University Hospital, Bordeaux | 2015-07-09 |
| The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration (NCT03326401) | Hacettepe University | 2015-07-01 |
| Multimodal Imaging of Retinal Vessels (NCT02717026) | Medical University of Graz | 2015-07-01 |
| SD-OCT Angiography (NCT02510885) | Duke University | 2015-07-01 |
| Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration (NCT02511613) | Ohr Pharmaceutical Inc. | 2015-07-01 |
| Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD (NCT02467634) | StemCells, Inc. | 2015-06-01 |
| IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD (NCT02462889) | Jeffrey S Heier | 2015-06-01 |
| Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract (NCT03205202) | Brigham and Women's Hospital | 2015-06-01 |
| Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol (NCT02227498) | Second Sight Medical Products | 2015-06-01 |
| Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration (NCT02302989) | Leonard Feiner, MD, PhD | 2015-05-01 |
| Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration (NCT04468373) | VisionCare, Inc. | 2015-05-01 |
| Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. (NCT02140411) | Novartis Pharmaceuticals | 2015-04-25 |
| Smartphone Screening for Eye Diseases (NCT03076697) | University of Michigan | 2015-04-16 |
| The Role of Inflammation in AMD and Related Disorders (NCT02588378) | Unity Health Toronto | 2015-04-01 |
| A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration (NCT02401945) | Santen Inc. | 2015-04-01 |
| Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD (NCT02357342) | Maturi, Raj K., M.D., P.C. | 2015-04-01 |
| Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration (NCT02422160) | Stanford University | 2015-04-01 |
| The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy Subjects (NCT02102880) | Medical University of Vienna | 2015-03-01 |
| Phase 1 Study of CM082 in Patients With wAMD (NCT02452385) | AnewPharma | 2015-03-01 |
| The Focal Electro-Oculogram in Macular Disease (NCT02225119) | National Eye Institute (NEI) | 2015-02-06 |
| Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. (NCT02571972) | Wills Eye | 2015-02-01 |
| Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (NCT02358889) | Iconic Therapeutics, Inc. | 2015-02-01 |
| Risk Factors for Drusen Progression (NCT01830608) | Medical University of Vienna | 2015-01-01 |
| Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort (NCT07424235) | IRCCS Ospedale San Raffaele | 2015-01-01 |
| Evaluation of the Distortion Correction Data Collection (DCDC) App Software (NCT02337647) | University of Nebraska | 2014-12-29 |
| Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept (NCT02291887) | Associated Retinal Consultants, Michigan | 2014-12-22 |
| Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients (NCT02296567) | East Florida Eye Institute | 2014-12-01 |
| Reticular Pseudodrusen Progression Study (NCT02345317) | University Hospital Muenster | 2014-12-01 |
| Single or Combined Protocols for NV-AMD (NCT03552770) | University Hospital of Ferrara | 2014-11-23 |
| Sildenafil for Treatment of Choroidal Ischemia (NCT04356716) | Columbia University | 2014-11-11 |
| A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration (NCT02314299) | Stealth BioTherapeutics Inc. | 2014-11-01 |
| VITAL - Individualising Therapy for Neovascular AMD With Aflibercept (NCT02441816) | Moorfields Eye Hospital NHS Foundation Trust | 2014-11-01 |
| Sparing of the Fovea in Geographic Atrophy Progression (NCT02332343) | University Hospital, Bonn | 2014-10-01 |
| Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy (NCT02261194) | Maisonneuve-Rosemont Hospital | 2014-10-01 |
| Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR) (NCT02173496) | Aston University | 2014-10-01 |
| Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (NCT02140151) | Southern California Desert Retina Consultants, MC | 2014-09-17 |
| Intravitreal Injections of Ziv-aflibercept for Macular Diseases (NCT02556723) | Retina Clinic, Sao Paulo, Brazil | 2014-09-01 |
| Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198 (NCT02226835) | National Eye Institute (NEI) | 2014-08-13 |
| Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD (NCT02218177) | University Health Network, Toronto | 2014-08-01 |
| Development of a Device to Measure Dark Adaptation (NCT02090751) | University of Manchester | 2014-07-01 |